SORT BY

FILTER BY

fastest growing stats

Fastest Growing Companies

Jay Fram

73

Biogen

BIIB

Multiple sclerosis drug Tecfidera continues to boost revenue for this biotech–a stalwart of this list, appearing for the seventh time.

Location

Cambridge, Mass.

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

2

Years on List

7

CEO

George Scangos

Biogen is also featured in these fortune lists
Revenue and net income for the four quarters ended on or before April 30, 2016.Total return for the period ended June 30, 2016.
Revenue, Net Income
$ millions
Revenue Past Four Quarters ($M)$10,936
Net Income Past Four Quarters ($M)$3,695
Growth Rates and Ranks
Revenue 3 Yr Growth Rank53
EPS 3 Yr Annual Growth Rate42%
EPS 3 Yr Growth Rank44
Total Return 3 Yr Annual Rate4%
Total Return 3 Yr Rank94
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Biogen

Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals

Both Merck and Allergan are reportedly exploring a buyout.

Read More →
Drug Companies Really Don’t Care About the Price Hike Backlash

Companies continued to raise prices significantly in Q1.

Read More →
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?

Biotech companies are staking big money on the idea that they can relieve pain without addiction.

Read More →
How Medical Researchers Are Breaking the Blood-Brain Barrier

Better drugs for Alzheimer's and other brain disorders could follow.

Read More →